{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:41:59Z","timestamp":1760258519185,"version":"build-2065373602"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jaut.2013.06.012","type":"journal-article","created":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T21:01:02Z","timestamp":1374354062000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes"],"prefix":"10.1016","volume":"45","author":[{"given":"Birgit","family":"Knoechel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens G.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.06.012_bib1","first-page":"4","article-title":"Current and future immunomodulation strategies to restore tolerance in autoimmune diseases","author":"Bluestone","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaut.2013.06.012_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.06.012_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib5","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.288.5475.2354","article-title":"Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations","volume":"288","author":"Siegel","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.06.012_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of malignant lymphomas\u2013an update","volume":"264","author":"Smedby","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"Goldin","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaut.2013.06.012_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2009.07.002","article-title":"Secondary tumours in Sjogren's syndrome","volume":"9","author":"Kovacs","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.06.012_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2010.02.005","article-title":"Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID)","volume":"9","author":"Schuetz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.06.012_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaut.2012.09.002","article-title":"Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review","volume":"39","author":"Ngalamika","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.beha.2010.01.004","article-title":"Autoimmune complications in chronic lymphocytic leukaemia (CLL)","volume":"23","author":"Zent","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaut.2013.06.012_bib12","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","article-title":"Pathogenesis of myeloma","volume":"6","author":"Anderson","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaut.2013.06.012_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.06.012_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaut.2013.06.012_bib18","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI40591","article-title":"MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice","volume":"122","author":"Rivas","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.06.012_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.06.012_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib27","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2013.06.012_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20050855","article-title":"Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen","volume":"202","author":"Knoechel","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib32","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.4049\/jimmunol.176.11.6473","article-title":"Functional and molecular comparison of anergic and regulatory T lymphocytes","volume":"176","author":"Knoechel","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory B and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2013.06.012_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaut.2013.06.012_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The life history of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib41","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2012-01-405977","article-title":"Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides","volume":"120","author":"Egan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2013.06.012_bib44","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib45","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMct1114348","article-title":"Anti-CD20 antibody therapy for B-cell lymphomas","volume":"366","author":"Maloney","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","article-title":"Rituximab in the treatment of autoimmune haematological disorders","volume":"141","author":"Garvey","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2013.06.012_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1126\/science.1223730","article-title":"Molecular biology. Genetic events that shape the cancer epigenome","volume":"336","author":"Ryan","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.06.012_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cell.2012.02.045","article-title":"Regulated noise in the epigenetic landscape of development and disease","volume":"148","author":"Pujadas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity","volume":"39","author":"Selmi","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-009-8168-4","article-title":"Epigenetics lessons from twins: prospects for autoimmune disease","volume":"39","author":"Ballestar","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg2905","article-title":"Charting histone modifications and the functional organization of mammalian genomes","volume":"12","author":"Zhou","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2011.01.024","article-title":"Functional and mechanistic diversity of distal transcription enhancers","volume":"144","author":"Bulger","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib57","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/MCB.01206-10","article-title":"Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival","volume":"31","author":"Beier","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaut.2013.06.012_bib58","doi-asserted-by":"crossref","first-page":"16894","DOI":"10.1073\/pnas.0607926103","article-title":"Interaction of GATA-3\/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1\/Th2 lymphocytes","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib59","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1101\/gad.1689708","article-title":"Coordinated but physically separable interaction with H3K27-demethylase and H3K4-methyltransferase activities are required for T-box protein-mediated activation of developmental gene expression","volume":"22","author":"Miller","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaut.2013.06.012_bib60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molcel.2010.10.028","article-title":"Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression","volume":"40","author":"Miller","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20061085","article-title":"Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription","volume":"400","author":"Han","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.jaut.2013.06.012_bib62","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.4049\/jimmunol.177.11.7656","article-title":"Regulation of Th2 cell development by polycomb group gene bmi-1 through the stabilization of GATA3","volume":"177","author":"Hosokawa","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein ezh2 controls actin polymerization and cell signaling","volume":"121","author":"Su","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Su","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"Beguelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib66","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib69","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","article-title":"The epigenetics of autoimmunity","volume":"8","author":"Meda","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2008.03.003","article-title":"DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients","volume":"7","author":"Zhou","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.06.012_bib72","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1","article-title":"Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression","volume":"43","author":"Neidhart","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.06.012_bib73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","article-title":"Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus","volume":"41","author":"Zhang","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2013.06.012_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar4074","article-title":"Epigenetic contributions in the development of rheumatoid arthritis","volume":"14","author":"Klein","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2013.06.012_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2040620712466864","article-title":"Epigenetic therapy of hematological malignancies: where are we now?","volume":"4","author":"Popovic","year":"2013","journal-title":"Ther Adv Hematol"},{"issue":"71 Suppl.\u00a02","key":"10.1016\/j.jaut.2013.06.012_bib77","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","author":"Hancock","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2013.06.012_bib78","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.052702999","article-title":"The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines","volume":"99","author":"Leoni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib79","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1525-0016(03)00235-1","article-title":"A\u00a0therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis","volume":"8","author":"Chung","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaut.2013.06.012_bib80","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/art.20709","article-title":"Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1\/Cip1) expression","volume":"50","author":"Nishida","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.06.012_bib81","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1073\/pnas.1212264109","article-title":"Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors","volume":"109","author":"Bandukwala","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib82","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/blood-2012-08-451765","article-title":"Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly \u2013 T cells in human health and disease","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","author":"Sakaguchi","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib85","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib86","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gad.1890510","article-title":"Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma","volume":"24","author":"Inda","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaut.2013.06.012_bib87","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib89","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2007-06-097014","article-title":"Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30","volume":"110","author":"Oflazoglu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by\u00a0enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib92","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-7-152","article-title":"The BRCA1\/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers","volume":"7","author":"Friedenson","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaut.2013.06.012_bib93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/76950","article-title":"Brca1 required for T cell lineage development but not TCR loci rearrangement","volume":"1","author":"Mak","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib94","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.06.012_bib95","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.06.012_bib96","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/leu.2012.278","article-title":"Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene","volume":"27","author":"Diaz-Beya","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2013.06.012_bib97","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/MCB.01598-08","article-title":"Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development","volume":"29","author":"Fukuyama","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaut.2013.06.012_bib98","first-page":"804","article-title":"Abnormal histone modification patterns in lupus CD4+ T cells","volume":"35","author":"Hu","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2013.06.012_bib99","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1182\/blood-2005-08-3263","article-title":"Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells","volume":"107","author":"Xu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib100","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.4049\/jimmunol.178.11.6941","article-title":"p300 protein acetyltransferase activity suppresses systemic lupus erythematosus-like autoimmune disease in mice","volume":"178","author":"Forster","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib101","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/bcj.2011.31","article-title":"Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms","volume":"1","author":"Brecqueville","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jaut.2013.06.012_bib102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/emboj.2012.350","article-title":"BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling","volume":"32","author":"Chaiyachati","year":"2013","journal-title":"Embo J"},{"key":"10.1016\/j.jaut.2013.06.012_bib103","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2011-07-367243","article-title":"Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"119","author":"Score","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib104","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.onc.1205051","article-title":"The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas","volume":"21","author":"Richie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jaut.2013.06.012_bib105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2133.2011.10646.x","article-title":"Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata","volume":"166","author":"Zhao","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaut.2013.06.012_bib106","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/leu.2008.128","article-title":"Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique","volume":"22","author":"Gervais","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2013.06.012_bib107","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/gcc.20022","article-title":"Type I MOZ\/CBP (MYST3\/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation","volume":"40","author":"Rozman","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jaut.2013.06.012_bib108","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood-2010-10-312736","article-title":"KDM2b\/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia","volume":"117","author":"He","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib109","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/leu.2012.56","article-title":"Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia","volume":"26","author":"Mar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2013.06.012_bib110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/humu.22229","article-title":"KDM6A point mutations cause Kabuki syndrome","volume":"34","author":"Miyake","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaut.2013.06.012_bib111","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajmg.a.30722","article-title":"Immune abnormalities are a frequent manifestation of Kabuki syndrome","volume":"135","author":"Hoffman","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaut.2013.06.012_bib112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaut.2013.06.012_bib113","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.4049\/jimmunol.1100550","article-title":"c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus","volume":"187","author":"Kozuka","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.06.012_bib114","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2009-05-223255","article-title":"c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development","volume":"116","author":"Nakata","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2006.03.017","article-title":"Crucial role of MLL for the maintenance of memory T helper type 2 cell responses","volume":"24","author":"Yamashita","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.06.012_bib116","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.06.012_bib117","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng.646","article-title":"Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome","volume":"42","author":"Ng","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib118","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1182\/blood-2011-12-401471","article-title":"Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing","volume":"120","author":"Dolnik","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib119","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2010-07-298349","article-title":"The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells","volume":"117","author":"Martinez-Garcia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ng.788","article-title":"Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia","volume":"43","author":"Yan","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib122","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib123","doi-asserted-by":"crossref","first-page":"22900","DOI":"10.1074\/jbc.M111.312785","article-title":"De novo DNA methylation is required to restrict T helper lineage plasticity","volume":"287","author":"Thomas","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2013.06.012_bib124","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1073\/pnas.1103803109","article-title":"DNA methyltransferase 3a limits the expression of interleukin-13 in T helper 2 cells and allergic airway inflammation","volume":"109","author":"Yu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.06.012_bib125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1196\/annals.1422.015","article-title":"DNA methylation and systemic lupus erythematosus","volume":"1108","author":"Balada","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.06.012_bib126","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib127","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with\u00a0TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib129","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.06.012_bib130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib131","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib132","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1182\/blood-2011-08-368225","article-title":"ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category","volume":"118","author":"Metzeler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib133","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2012-02-413021","article-title":"BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia","volume":"120","author":"Ott","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.06.012_bib134","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.06.012_bib135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.06.012_bib136","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/leu.2010.247","article-title":"PHF6 mutations in adult acute myeloid leukemia","volume":"25","author":"Van Vlierberghe","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2013.06.012_bib137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2012.05.004","article-title":"Pierre Youinou: when intuition and determination meet autoimmunity","volume":"39","author":"Jamin","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib138","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2011.05.011","article-title":"Chella David: a lifetime contribution in translational immunology","volume":"37","author":"Gershwin","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib139","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sjogren's syndrome: what we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.06.012_bib140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","article-title":"Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop","volume":"39","author":"Selmi","year":"2012","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:36Z","timestamp":1760256396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":140,"alternative-id":["S0896841113000863"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.06.012","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}